Dynavax Technologies Stock Z Score
DVAX Stock | USD 12.41 0.04 0.32% |
Dynavax | Z Score |
Dynavax Z Score Analysis
Dynavax Technologies' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
More About Z Score | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Total Liabilities | 816.9M | 404.8M | 375.0M | 393.8M | Other Stockholder Equity | 1.4B | 1.5B | 1.6B | 1.6B |
Z Score | = | Sum Of | | 5 Factors |
Current Dynavax Technologies Z Score | 3.74 |
Most of Dynavax Technologies' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
Dynavax Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Z Score. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition |
According to the company's disclosures, Dynavax Technologies has a Z Score of 3.74. This is 44.59% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is 57.11% higher than that of the company.
Dynavax Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.Dynavax Technologies is currently under evaluation in z score category among related companies.
Dynavax Technologies Institutional Holders
Institutional Holdings refers to the ownership stake in Dynavax Technologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dynavax Technologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dynavax Technologies' value.Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.5 M | Blair William & Co | 2023-12-31 | 2.4 M | Renaissance Technologies Corp | 2023-12-31 | 1.9 M | Rock Springs Capital Management Lp | 2023-12-31 | 1.7 M | Driehaus Capital Management Llc | 2023-12-31 | 1.6 M | Kynam Capital Management, Lp | 2023-12-31 | 1.5 M | Northern Trust Corp | 2023-12-31 | 1.4 M | Fisher Asset Management, Llc | 2023-12-31 | 1.4 M | Woodline Partners Lp | 2023-12-31 | 1.3 M | Blackrock Inc | 2023-12-31 | 23.4 M | Federated Hermes Inc | 2023-12-31 | 11.4 M |
Dynavax Fundamentals
Return On Equity | -0.0106 | ||||
Return On Asset | -0.0192 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | (0.12) % | ||||
Current Valuation | 1.14 B | ||||
Shares Outstanding | 130.62 M | ||||
Shares Owned By Insiders | 0.29 % | ||||
Shares Owned By Institutions | 98.11 % | ||||
Number Of Shares Shorted | 17.35 M | ||||
Price To Earning | 6.95 X | ||||
Price To Book | 2.61 X | ||||
Price To Sales | 6.98 X | ||||
Revenue | 232.28 M | ||||
Gross Profit | 448.22 M | ||||
EBITDA | 20.98 M | ||||
Net Income | (6.39 M) | ||||
Cash And Equivalents | 518.17 M | ||||
Cash Per Share | 4.10 X | ||||
Total Debt | 256.91 M | ||||
Debt To Equity | 0.61 % | ||||
Current Ratio | 2.77 X | ||||
Book Value Per Share | 4.80 X | ||||
Cash Flow From Operations | 100.56 M | ||||
Short Ratio | 7.94 X | ||||
Earnings Per Share | (0.05) X | ||||
Target Price | 25.75 | ||||
Number Of Employees | 408 | ||||
Beta | 1.25 | ||||
Market Capitalization | 1.62 B | ||||
Total Asset | 997.1 M | ||||
Retained Earnings | (930.58 M) | ||||
Working Capital | 796.92 M | ||||
Current Asset | 199.95 M | ||||
Current Liabilities | 28.79 M | ||||
Z Score | 3.74 | ||||
Net Asset | 997.1 M |
About Dynavax Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people.
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Dynavax Stock
0.66 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.83 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Dynavax Stock
0.8 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.77 | MGNX | MacroGenics Financial Report 14th of May 2024 | PairCorr |
0.63 | MDWD | Mediwound Downward Rally | PairCorr |
0.53 | CLVRW | Clever Leaves Holdings | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dynavax Technologies Piotroski F Score and Dynavax Technologies Valuation analysis. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stocks Directory Find actively traded stocks across global markets | |
Transaction History View history of all your transactions and understand their impact on performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.